skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 96  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: language: Russian remove Database: HighWire Press (Free Journals) remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Cigarette, Cigar, and Pipe Smoking and the Risk of Head and Neck Cancers: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium
Material Type:
Article
Add to My Research

Cigarette, Cigar, and Pipe Smoking and the Risk of Head and Neck Cancers: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium

American journal of epidemiology, 2013-09, Vol.178 (5), p.679-690 [Peer Reviewed Journal]

2014 INIST-CNRS ;Copyright Oxford Publishing Limited(England) Sep 1, 2013 ;The Author 2013. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2013 ;ISSN: 0002-9262 ;EISSN: 1476-6256 ;DOI: 10.1093/aje/kwt029 ;PMID: 23817919 ;CODEN: AJEPAS

Full text available

2
Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib
Material Type:
Article
Add to My Research

Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib

Blood, 2011-10, Vol.118 (17), p.4567-4576 [Peer Reviewed Journal]

2011 American Society of Hematology ;2015 INIST-CNRS ;2011 by The American Society of Hematology 2011 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2011-05-355594 ;PMID: 21865346

Full text available

3
Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure
Material Type:
Article
Add to My Research

Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure

Blood, 2012-04, Vol.119 (15), p.3403-3412 [Peer Reviewed Journal]

2012 American Society of Hematology ;2015 INIST-CNRS ;2012 by The American Society of Hematology 2012 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2011-11-390120 ;PMID: 22371878

Full text available

4
Randomized Phase Ib/II Trial of Rilotumumab or Ganitumab with Panitumumab versus Panitumumab Alone in Patients with Wild-type KRAS Metastatic Colorectal Cancer
Material Type:
Article
Add to My Research

Randomized Phase Ib/II Trial of Rilotumumab or Ganitumab with Panitumumab versus Panitumumab Alone in Patients with Wild-type KRAS Metastatic Colorectal Cancer

Clinical cancer research, 2014-08, Vol.20 (16), p.4240-4250 [Peer Reviewed Journal]

2015 INIST-CNRS ;2014 American Association for Cancer Research. ;2014 American Association for Cancer Research. 2014 ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-13-2752 ;PMID: 24919569 ;CODEN: CCREF4

Full text available

5
Ambulatory Hypertension Subtypes and 24-Hour Systolic and Diastolic Blood Pressure as Distinct Outcome Predictors in 8341 Untreated People Recruited From 12 Populations
Material Type:
Article
Add to My Research

Ambulatory Hypertension Subtypes and 24-Hour Systolic and Diastolic Blood Pressure as Distinct Outcome Predictors in 8341 Untreated People Recruited From 12 Populations

Circulation (New York, N.Y.), 2014-08, Vol.130 (6), p.466-474 [Peer Reviewed Journal]

2014 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2015 INIST-CNRS ;2014 American Heart Association, Inc. ;2014 American Heart Association, Inc. 2014 ;ISSN: 0009-7322 ;ISSN: 1524-4539 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.113.004876 ;PMID: 24906822 ;CODEN: CIRCAZ

Full text available

6
Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study
Material Type:
Article
Add to My Research

Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study

Blood, 2010-11, Vol.116 (20), p.4095-4098 [Peer Reviewed Journal]

2010 American Society of Hematology ;2015 INIST-CNRS ;2010 by The American Society of Hematology ;ISSN: 0006-4971 ;ISSN: 1528-0020 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2010-06-293902 ;PMID: 20713962

Full text available

7
Increased chromosome instability dramatically disrupts neural genome integrity and mediates cerebellar degeneration in the ataxia-telangiectasia brain
Material Type:
Article
Add to My Research

Increased chromosome instability dramatically disrupts neural genome integrity and mediates cerebellar degeneration in the ataxia-telangiectasia brain

Human molecular genetics, 2009-07, Vol.18 (14), p.2656-2669 [Peer Reviewed Journal]

The Author 2009. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org 2009 ;2009 INIST-CNRS ;ISSN: 0964-6906 ;EISSN: 1460-2083 ;DOI: 10.1093/hmg/ddp207 ;PMID: 19414482 ;CODEN: HNGEE5

Full text available

8
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
Material Type:
Article
Add to My Research

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

Annals of the rheumatic diseases, 2010-10, Vol.69 (10), p.1809-1815 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2015 INIST-CNRS ;Copyright: 2010 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0003-4967 ;ISSN: 1468-2060 ;EISSN: 1468-2060 ;DOI: 10.1136/ard.2009.114264 ;PMID: 20551155 ;CODEN: ARDIAO

Full text available

9
The NFATc2 Gene Is Involved in a Novel Cloned Translocation in a Ewing Sarcoma Variant That Couples Its Function in Immunology to Oncology
Material Type:
Article
Add to My Research

The NFATc2 Gene Is Involved in a Novel Cloned Translocation in a Ewing Sarcoma Variant That Couples Its Function in Immunology to Oncology

Clinical cancer research, 2009-04, Vol.15 (7), p.2259-2268 [Peer Reviewed Journal]

2009 INIST-CNRS ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-08-2184 ;PMID: 19318479 ;CODEN: CCREF4

Full text available

10
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
Material Type:
Article
Add to My Research

Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation

Blood, 2010-11, Vol.116 (20), p.4360-4367 [Peer Reviewed Journal]

2010 American Society of Hematology ;2015 INIST-CNRS ;ISSN: 0006-4971 ;ISSN: 1528-0020 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2010-01-262089 ;PMID: 20625005

Full text available

11
Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-up
Material Type:
Article
Add to My Research

Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-up

Blood, 2009-06, Vol.113 (25), p.6322-6329 [Peer Reviewed Journal]

2009 American Society of Hematology ;2009 INIST-CNRS ;2009 by The American Society of Hematology 2009 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2008-11-186817 ;PMID: 19369231

Full text available

12
Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials
Material Type:
Article
Add to My Research

Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials

European heart journal, 2009-12, Vol.30 (24), p.3015-3026 [Peer Reviewed Journal]

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org 2009 ;2015 INIST-CNRS ;Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org ;ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehp338 ;PMID: 19700774

Full text available

13
Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study
Material Type:
Article
Add to My Research

Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study

Clinical cancer research, 2014-01, Vol.20 (2), p.511-521 [Peer Reviewed Journal]

2015 INIST-CNRS ;2014 AACR. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-13-0239 ;PMID: 24443618 ;CODEN: CCREF4

Full text available

14
Alcohol poisoning is a main determinant of recent mortality trends in Russia: evidence from a detailed analysis of mortality statistics and autopsies
Material Type:
Article
Add to My Research

Alcohol poisoning is a main determinant of recent mortality trends in Russia: evidence from a detailed analysis of mortality statistics and autopsies

International journal of epidemiology, 2009-02, Vol.38 (1), p.143-153 [Peer Reviewed Journal]

Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2008; all rights reserved. 2008 ;2009 INIST-CNRS ;ISSN: 0300-5771 ;EISSN: 1464-3685 ;DOI: 10.1093/ije/dyn160 ;PMID: 18775875 ;CODEN: IJEPBF

Full text available

15
Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial
Material Type:
Article
Add to My Research

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial

Annals of oncology, 2009-04, Vol.20 (4), p.666-673 [Peer Reviewed Journal]

The Author 2009. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org 2009 ;2009 INIST-CNRS ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdn717 ;PMID: 19153121

Full text available

16
The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis
Material Type:
Article
Add to My Research

The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis

Annals of the rheumatic diseases, 2010-03, Vol.69 (3), p.495-502 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2015 INIST-CNRS ;Copyright: 2010 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard.2009.122473 ;PMID: 20223838 ;CODEN: ARDIAO

Full text available

17
European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis
Material Type:
Article
Add to My Research

European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis

Annals of the Rheumatic Diseases, 2011-04, Vol.70 (4), p.563-570 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2015 INIST-CNRS ;Copyright: 2011 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard.2010.139105 ;PMID: 21216817 ;CODEN: ARDIAO

Full text available

18
Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium
Material Type:
Article
Add to My Research

Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium

International journal of epidemiology, 2010-02, Vol.39 (1), p.166-181 [Peer Reviewed Journal]

Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2009; all rights reserved. 2009 ;2015 INIST-CNRS ;ISSN: 0300-5771 ;EISSN: 1464-3685 ;DOI: 10.1093/ije/dyp350 ;PMID: 20022926 ;CODEN: IJEPBF

Full text available

19
Neuroblastoma amplified sequence gene is associated with a novel short stature syndrome characterised by optic nerve atrophy and Pelger–Huët anomaly
Material Type:
Article
Add to My Research

Neuroblastoma amplified sequence gene is associated with a novel short stature syndrome characterised by optic nerve atrophy and Pelger–Huët anomaly

Journal of medical genetics, 2010-08, Vol.47 (8), p.538-548 [Peer Reviewed Journal]

2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;2015 INIST-CNRS ;Copyright: 2010 (c) 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. 2010 ;ISSN: 0022-2593 ;EISSN: 1468-6244 ;DOI: 10.1136/jmg.2009.074815 ;PMID: 20577004 ;CODEN: JMDGAE

Full text available

20
Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: Results of the XPECT trial
Material Type:
Article
Add to My Research

Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: Results of the XPECT trial

Circulation. Arrhythmia and electrophysiology, 2010-04, Vol.3 (2), p.141 [Peer Reviewed Journal]

EISSN: 1941-3084 ;DOI: 10.1161/CIRCEP.109.877852 ;PMID: 20160169

Digital Resources/Online E-Resources

Results 1 - 20 of 96  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait